| 1 |
32706283 | P-Glycoprotein-Mediated Efflux Using a Rapidly Maturing Caco2 Clone (CLEFF4) in Only 5 Days without Requiring Modified Growth Medium. | 2021 Jan |
1 |
| 2 |
34066059 | Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells. | 2021 May 12 |
1 |
| 3 |
32275773 | P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. | 2020 Sep |
1 |
| 4 |
32710919 | Boosting drug bioavailability in men but not women through the action of an excipient. | 2020 Sep 25 |
1 |
| 5 |
27926506 | Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar. | 2017 Jan 10 |
1 |
| 6 |
27783718 | Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole. | 2016 Nov |
2 |
| 7 |
25597754 | The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations. | 2015 Apr |
1 |
| 8 |
24700236 | PARP Inhibitors as P-glyoprotein Substrates. | 2014 Jun |
1 |
| 9 |
22118813 | ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells. | 2012 Feb 28 |
2 |
| 10 |
21318225 | Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells. | 2011 Apr |
1 |
| 11 |
24309308 | Role of p-glycoprotein expression and function in cystinotic renal proximal tubular cells. | 2011 Oct 27 |
1 |
| 12 |
19188390 | P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. | 2009 Apr |
1 |
| 13 |
19423841 | Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells. | 2009 Aug |
4 |
| 14 |
17947497 | Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. | 2008 Jan |
1 |
| 15 |
18396325 | Teasing apart activities of different types of ABC efflux pumps in bivalve gills using the concepts of independent action and concentration addition. | 2008 Jul |
1 |
| 16 |
15993035 | Development of multidrug resistance type I P-glycoprotein function during in vitro maturation of porcine oocyte. | 2006 Jan |
1 |
| 17 |
16223781 | Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. | 2006 Feb 15 |
1 |
| 18 |
16299163 | Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats. | 2006 Feb |
2 |
| 19 |
16671962 | Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein. | 2006 Jun |
1 |
| 20 |
15788683 | Cyclosporin A is a broad-spectrum multidrug resistance modulator. | 2005 Mar 15 |
1 |
| 21 |
21783614 | Diazinon cytotoxicity and transfer in Caco-2 cells: Effect of long-term exposure to the pesticide. | 2005 Sep |
2 |
| 22 |
15244080 | pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study. | 2004 May |
1 |
| 23 |
15322734 | Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice. | 2004 Aug |
1 |
| 24 |
15358539 | Transport of somatostatin and substance P by human P-glycoprotein. | 2004 Sep 10 |
1 |
| 25 |
15384974 | The expression of P-glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors. | 2004 Oct |
3 |
| 26 |
15472518 | Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. | 2004 Sep |
2 |
| 27 |
12822513 | Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice. | 2003 Mar-Apr |
1 |
| 28 |
14641819 | Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells. | 2003 May-Jun |
1 |
| 29 |
12152989 | P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype. | 2002 Jun |
1 |
| 30 |
11123865 | Overcoming drug resistance in ovarian carcinoma. | 2001 Jan |
1 |
| 31 |
11284449 | P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin. | 2001 Mar |
4 |
| 32 |
11408492 | Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study. | 2001 Jun 15 |
1 |
| 33 |
11566278 | Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells. | 2001 Sep 15 |
1 |
| 34 |
11676863 | Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15. | 2001 Oct |
1 |
| 35 |
10636889 | Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. | 2000 Jan 21 |
4 |
| 36 |
10784624 | P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia. | 2000 May |
3 |
| 37 |
10832593 | Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells. | 2000 Feb |
1 |
| 38 |
10837354 | Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells. | 2000 Jun |
1 |
| 39 |
10955805 | P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. | 2000 Aug |
1 |
| 40 |
10997946 | Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. | 2000 Oct |
1 |
| 41 |
10368654 | Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). | 1999 Mar-Apr |
2 |
| 42 |
9530286 | HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. | 1998 Mar 17 |
1 |
| 43 |
9914792 | Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein. | 1998 Nov |
7 |
| 44 |
9038218 | Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. | 1997 Feb 28 |
1 |
| 45 |
9205006 | Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts. | 1997 Jul |
1 |
| 46 |
8616825 | Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies. | 1996 Feb 6 |
1 |
| 47 |
7559918 | Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs. | 1995 May |
1 |